Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Genomics BioSci & Tech. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.06	172.58	253.03	317	107.5	476.94
Short-Term Investments	34.6	65	-	-	-	98
Cash & Short-Term Investments	126.66	237.58	253.03	317	107.5	574.94
Cash Growth	-	-6.11%	-20.18%	194.90%	-81.30%	36.20%
Accounts Receivable	155.07	138.86	116.1	100.02	81.75	79.18
Other Receivables	0.21	0.39	0.74	0.01	1.44	0.58
Receivables	155.28	139.25	116.84	100.02	83.2	79.77
Inventory	229.58	185.49	61.51	54.8	20.99	24
Prepaid Expenses	17.78	18.09	16.85	8.83	21.92	26.88
Other Current Assets	30.06	34.77	23.58	17.45	18.23	12.38
Total Current Assets	559.36	615.19	471.82	498.1	251.83	717.96
Property, Plant & Equipment	660.81	648.43	498.69	373.37	311.02	306
Long-Term Investments	114.6	82	153.98	237.96	285.83	110.32
Other Intangible Assets	5.39	5.77	1.73	0.86	1.16	3.92
Long-Term Accounts Receivable	0.16	0.64	-	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	0.07	0.1
Other Long-Term Assets	21.23	8.33	7.63	9.44	3.27	16.96
Total Assets	1,362	1,360	1,134	1,120	853.18	1,155
Accounts Payable	112.73	97.4	29.73	40.47	27.31	31.41
Accrued Expenses	41.62	35.4	28.7	34.5	27.54	71.93
Short-Term Debt	203.4	128.96	50	50	-	50
Current Portion of Long-Term Debt	49.71	35.41	4.86	12.4	3.9	3.87
Current Portion of Leases	5.47	6.43	6.51	4.75	3.39	5.23
Current Income Taxes Payable	-	-	-	0.58	-	-
Current Unearned Revenue	10.16	43.69	12.72	20	18.89	11.99
Other Current Liabilities	12.8	35.48	13.57	6.21	13.57	14.58
Total Current Liabilities	435.9	382.77	146.09	168.91	94.59	189.02
Long-Term Debt	305.44	328.89	214.01	153.35	75.67	44.22
Long-Term Leases	7.09	7.98	8.24	8.34	3.58	14.32
Other Long-Term Liabilities	0.01	-	-	-	-	-
Total Liabilities	748.44	719.64	368.33	330.6	173.84	247.56
Common Stock	724.48	724.48	724.48	630.28	578.92	578.92
Additional Paid-In Capital	1.07	30.15	131.53	58.91	43.76	38.88
Retained Earnings	-188.51	-204.06	-88.24	101.85	36.07	16.09
Comprehensive Income & Other	-2.35	-1.84	-2.25	-1.91	20.59	38.29
Total Common Equity	534.7	548.73	765.51	789.13	679.34	672.18
Minority Interest	78.42	91.99	-	-	-	235.52
Shareholders' Equity	613.12	640.73	765.51	789.13	679.34	907.7
Total Liabilities & Equity	1,362	1,360	1,134	1,120	853.18	1,155
Total Debt	571.12	507.67	283.61	228.84	86.53	117.64
Net Cash (Debt)	-444.46	-270.08	-30.58	88.17	20.96	457.3
Net Cash Growth	-	-	-	320.57%	-95.42%	24.15%
Net Cash Per Share	-6.13	-3.73	-0.43	1.39	0.35	7.58
Filing Date Shares Outstanding	72.45	72.45	72.45	64.29	60.23	60.23
Total Common Shares Outstanding	72.45	72.45	72.45	64.29	60.23	60.23
Working Capital	123.47	232.42	325.73	329.19	157.24	528.94
Book Value Per Share	7.38	7.57	10.57	12.27	11.28	11.16
Tangible Book Value	529.31	542.96	763.78	788.27	678.18	668.26
Tangible Book Value Per Share	7.31	7.49	10.54	12.26	11.26	11.10
Land	206.74	206.74	139.79	104.76	104.76	86.67
Buildings	266.97	256.36	211.33	144.63	134.61	101.25
Machinery	322.94	234.39	231.91	142.81	150.45	234.52
Construction In Progress	0.39	52.59	0.23	79.45	26.25	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.